Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Ritter

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Lancet (London, England)|March 5, 2023
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studiesWilliam J Sandborn, Séverine Vermeire, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|June 15, 2024
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 TrialsSéverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT ExperienceAbhishek A Solanki, Kevin Zheng, Alicia N Skipworth, et al.
Lancet (London, England)|June 6, 2021
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trialBrian G Feagan, Silvio Danese, Edward V Loftus, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation OncologyCharles S Mayo, Jean M Moran, Walter Bosch, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Lancet (London, England)|March 5, 2023
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studiesWilliam J Sandborn, Séverine Vermeire, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|June 15, 2024
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 TrialsSéverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT ExperienceAbhishek A Solanki, Kevin Zheng, Alicia N Skipworth, et al.
Lancet (London, England)|June 6, 2021
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trialBrian G Feagan, Silvio Danese, Edward V Loftus, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2018
American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation OncologyCharles S Mayo, Jean M Moran, Walter Bosch, et al.
Pageof 5